Search Results 521-530 of 39082 for Two-phase

1. NAFLD and NASH research update - Mayo Clinic

   ... stage 2 to 3 liver fibrosis. ... Aqel, M.D., a specialist in gastroenterology and hepatology at Mayo Clinic's campus in Arizona is the primary investigator for ...

2. Breast self-exam for breast awareness - Mayo Clinic

   April 2, 2024. Elsevier Point of Care. Clinical Overview: Fibrocystic breast disease. https://www.clinicalkey.com. Accessed April 2, 2024. Related. Atypical ...

3. Clinical trials - Oncology (Medical)

   ... phase II dose (RP2D of APG2575 in combination with ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

4. HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

5. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

6. Skin cancer - Symptoms and causes - Mayo Clinic

   Apply again every two hours, or more often if you're swimming or sweating. Wear protective clothing. Wear dark, tightly woven clothes that cover your arms ...

7. Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia - Mayo Clinic

   Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

8. Study Of [18F]FAPI-74 PET In Patients With Gastrointestinal Cancers (18F-FAPI-74 GI) - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

9. Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations - Mayo Clinic

   BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multiple cohort study designed to evaluate the safety, pharmacokinetics (PK), optimal dosage ...

10. Living wills and advance directives for medical decisions - Mayo Clinic

    For example, a medical team may use advance directives when you're unable to talk and are terminally ill, seriously injured, in a coma, in the late stages of ...